The FDA Just Put Aesthetic Marketing on Notice. Is Your Med Spa's Social Media Next?
Your med spa marketing agency might understand Instagram. But do they understand medical advertising?
The aesthetics industry has become exceptionally good at marketing. Beautifully curated Instagram feeds, engaging Reels, impressive before-and-after transformations, influencer partnerships, and carefully constructed promotional campaigns have become essential components of how medical aesthetic practices attract new patients.
But somewhere along the way, the industry's obsession with creating content that converts has started to overshadow something significantly more important: the responsibility that comes with advertising medical treatments.
And the FDA just provided a very public reminder of why that matters.
On September 28, 2026, the FDA's Office of Prescription Drug Promotion issued an untitled letter to Evolus, the manufacturer of Jeuveau, regarding an Instagram promotional Reel. The agency determined that the promotion was false or misleading, citing concerns about overstated treatment efficacy, misleading representations of how quickly results develop, and the minimization of risks associated with a prescription injectable.
We're not talking about some obscure, unapproved product being marketed by an irresponsible company. We're talking about an established, FDA-approved neuromodulator and a major aesthetic pharmaceutical manufacturer.
If a major manufacturer with regulatory resources can get its Instagram marketing wrong, what makes you confident your med spa's content is getting it right?
What Actually Happened With Jeuveau?
The FDA reviewed an Instagram Reel featuring a Jeuveau patient discussing her experience, accompanied by treatment footage showing changes between Day 0 and Day 2. The accompanying promotional language emphasized rapid results and suggested that patients could achieve complete elimination of their frown lines.
The issue wasn't simply that a patient shared a positive experience. The FDA took exception to the broader impression created by the marketing. Jeuveau is approved for the temporary improvement of moderate to severe glabellar lines in adults, not the permanent elimination of wrinkles.
The agency also questioned the presentation of two-day results, noting that the supporting data came from exploratory endpoints that did not carry the same statistical weight or clinical response criteria as the pivotal study's primary endpoint.
The FDA also criticized the way the promotion compared a prescription injectable to an everyday beauty product, blurring the distinction between a medical procedure and a cosmetic purchase. And although risk information appeared in the Reel and its caption, the agency found that its presentation did not adequately balance the prominent discussion of benefits.
This wasn't a case of forgetting to insert a disclaimer. The problem was the overall message.
For anyone working in aesthetic medicine, that's a distinction worth understanding.
Your Marketing Agency Isn't Necessarily a Medical Marketing Expert
Over the years, I've worked with aesthetic practices that have invested significant amounts of money in marketing agencies, social media managers, graphic designers, and content creators.
Some are exceptionally talented at brand development, audience engagement, and lead generation. But understanding how to make a Reel perform well is not the same thing as understanding the regulatory responsibilities associated with marketing prescription medications and medical procedures.
A social media manager might write that a laser treatment permanently eliminates wrinkles, that a neuromodulator delivers flawless results, or that a regenerative procedure can reverse aging. Those statements may sound compelling in a caption, but they also communicate clinical claims that require appropriate support and may be misleading.
The same concerns can arise with before-and-after photographs, patient testimonials, promotional pricing, influencer relationships, and even the language used on a practice's website. A patient's exceptional outcome does not establish what every patient should expect-
and adding "results may vary" does not automatically resolve a misleading claim.
To be clear, the September 28 FDA letter was directed to the drug manufacturer under prescription-drug promotional requirements. It was not an enforcement action against medical spas, and the precise FDA rules applied to manufacturer advertising do not automatically apply in the same way to every independent practice.
However, med spas are still responsible for complying with applicable federal and state advertising requirements. The FTC's truth-in-advertising principles, state medical-board standards, professional licensing rules, and other requirements may all be relevant depending on the practice and its marketing.
You can outsource your social media. You cannot outsource your responsibility for what your practice communicates to patients.
Five Marketing Mistakes Aesthetic Practices Need to Stop Making
1. Promising Results You Cannot Guarantee
Words matter, particularly when those words describe a medical outcome. There is a meaningful difference between communicating that a treatment may improve the appearance of a concern and promising that it will eliminate that concern.
Terms such as "permanent," "guaranteed," "risk-free," and "complete transformation" deserve scrutiny, especially when the supporting evidence does not justify them.
This is particularly relevant when practices are promoting newer devices, regenerative treatments, combination protocols, and procedures being used outside established indications. Your marketing claims should reflect what the available evidence actually supports, including limitations, variability, and the appropriate clinical context.
2. Using Before-and-After Photos Without Considering the Full Story
Before-and-after photography is one of the most powerful marketing tools in aesthetics, but it also creates opportunities to misrepresent expected outcomes. Changes in lighting, makeup, facial expression, positioning, photo editing, and even the timing of the images can substantially influence how a result appears.
If your practice is featuring a particularly impressive transformation, consider whether the images accurately depict the treatment being advertised, whether additional procedures contributed to the result, and whether patients could reasonably assume that the pictured outcome is typical. Appropriate patient authorization and privacy protections are also essential when using identifiable patient photographs or testimonials.
If you are going to be using a lot of before and afters, now is a good time to review my blog from August 2025 Top 10 HIPAA Compliance Killers in Aesthetic Medical Practices (and How to Avoid Them)
3. Treating Prescription Treatments Like Retail Beauty Products
One of the most revealing aspects of the FDA's Jeuveau letter was its concern about messaging that made a prescription injectable seem interchangeable with ordinary beauty products.
Medical aesthetics can absolutely be approachable, luxurious, and enjoyable.
But neuromodulators, dermal fillers, prescription weight-loss medications, and energy-based procedures aren't the equivalent of purchasing a new serum.
These services involve patient selection, clinical assessment, informed consent, potential contraindications, complications, and professional judgment. Your marketing should generate interest without eliminating the medical context that makes these services fundamentally different from retail products.
4. Assuming a Disclaimer Fixes Everything
I see practices rely on disclaimers as though they're universal protection.
THEY AREN'T!
A misleading headline doesn't necessarily become acceptable because a disclaimer appears in tiny print. A Reel that makes dramatic promises throughout its first 30 seconds isn't automatically corrected by adding important information after most viewers have stopped watching. And an extraordinary testimonial cannot necessarily be made representative by appending "individual results may vary."
What matters is the overall impression consumers receive from the advertisement, including whether important qualifications are presented clearly and prominently.
5. Allowing Marketing to Go Live Without Clinical Oversight
This may be the most preventable issue of all. In many practices, the marketing agency creates content, an administrative employee reviews it for spelling and branding, and the post goes live without anyone with appropriate clinical expertise evaluating the claims.
A marketing calendar is not a clinical review process.
If your practice offers prescription medications, medical devices, or invasive procedures, someone qualified needs to evaluate the medical accuracy of promotional content before publication. That includes reviewing treatment claims, indications, outcome expectations, contraindications where relevant, and any references to FDA approval or clearance.
The process should also identify when specialized legal or regulatory review is warranted.
Compliance and Marketing Shouldn't Be Competing Priorities
One of the most frustrating misconceptions I encounter in aesthetic practice consulting is the belief that compliance somehow gets in the way of effective marketing. As though accurate claims, appropriate disclosures, and realistic treatment expectations make it harder to sell.
I would argue the opposite.
A practice that understands its treatment offerings, trains its staff appropriately, and communicates realistic expectations is often better positioned to build patient trust and support informed purchasing decisions. That same discipline should carry through the comprehensive consultation, the treatment plan, the informed-consent process, and follow-up care.
When your marketing promises something that your providers cannot consistently deliver, you've created a disconnect before the patient ever walks through your doors. Your clinical team is then left managing unrealistic expectations, price objections, dissatisfaction, and potentially avoidable complaints.
Effective marketing should attract the right patient for the right treatment with the right expectations. It shouldn't require your providers to undo whatever the Instagram caption promised.
The best marketing strategy isn't the one that generates the most attention. It's the one your clinical team can confidently stand behind.
What Should Your Practice Do Right Now?
I'm not suggesting every med spa owner needs to panic and remove their social media content. But I am suggesting that this is an appropriate time to look at your marketing through a different lens.
Start by reviewing your recent posts, paid advertisements, website treatment descriptions, and promotional emails. Look specifically at clinical claims, expectations around treatment results, before-and-after presentations, prescription product promotions, and any language suggesting that a treatment is safer, faster, more effective, or more permanent than the available evidence supports.
Next, evaluate the approval process itself. Who creates your content? Who reviews the clinical information? Does your marketing team have access to accurate treatment descriptions and manufacturer information? Are promotional claims reviewed before publication? And who is responsible for identifying when something requires additional regulatory guidance?
Finally, examine whether the experience you're advertising actually aligns with the experience you're delivering.
If your marketing promises personalized treatment planning, exceptional patient education, and comprehensive aesthetic care, your consultation and operational processes should support those promises.
If you are not delivering that experience, I suggest you understand what has shifted, and read my article from last month: The Aesthetic Patient Is Changing: What 2026 Med Spa Trends Mean for Your Practice and more from October 2025 The Apex Approach to Consultations, Education, and Lifetime Treatment Planning
This is where practice strategy becomes marketing strategy and marketing strategy becomes practice strategy!
Your Marketing Needs More Than a Content Calendar
At Apex Aesthetic Consulting, I work with aesthetic practices on far more than attracting new patients. We examine the systems behind the patient experience, including consultations, treatment planning, staff training, pricing, operational performance, and the compliance infrastructure necessary to support sustainable growth.
Because generating more leads is only valuable when your practice is prepared to convert them appropriately, deliver on expectations, and retain those patients over time.
My Apex Growth Intensive is designed to help practice owners take a focused look at what's working, what isn't, and where their greatest opportunities for improvement exist. That includes evaluating how marketing aligns with your services, operations, consultations, and overall growth strategy.
Explore the Apex Growth Intensive - Limited Time Savings of $500!
The Jeuveau letter should serve as a reminder to every aesthetic practice owner that marketing medical services requires a different level of attention than marketing everyday consumer products. You don't need to stop creating engaging content, building a recognizable brand, or pursuing aggressive growth goals.
You do need to make sure that the marketing behind that growth is accurate, defensible, and consistent with the clinical responsibilities of your practice.
Your marketing should build your business, not create the next problem you have to fix.
Disclaimer: This article is intended for educational and general business purposes and does not constitute legal advice. Specific advertising requirements vary by product, type of communication, professional role, and state. Practices should consult qualified legal or regulatory counsel regarding their obligations.
Comments